Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Trading Statement

3 Feb 2014 07:00

3 February 2014

Anpario plc

(“the Company” or “Anpario”)

Pre Close Trading Statement

Anpario, the international producer of natural feed additives for animal health, hygiene and nutrition, is pleased to release a Pre Close Trading Statement.

The Company expects to deliver results for the year ended 31December 2013 in line with market expectations. The results will be announced in early April 2014.

Anpario has delivered strong sales growth from all its international brands and this advance reflects the Company’s investment in expanding its sales and technical resources at its regional offices in Brazil, China and Malaysia.

The growing interest from potential customers in North America has encouraged the Company to establish a subsidiary in the United States. This new, wholly owned, subsidiary is based in South Carolina and includes sales, warehousing and distribution facilities to enable it to offer Anpario’s products throughout North America.

The United States operation complements subsidiaries already formed in Brazil and China and means the Company is now firmly located in the world’s three principal pig and poultry producing countries. These businesses serve territories which in total account for over half the world’s output of pigs and poultry and will provide a strong platform for future growth.

The balance sheet remains strong and debt free with cash balances of £4.8m at the year end.

The Company is greatly encouraged by the number of new opportunities opening up in existing and new markets as customers become increasingly aware of the performance enhancing value of Anpario’s product portfolio. Customers recognise the benefit of Anpario’s natural products that are increasingly replacing the traditional use of antibiotics. The Company’s investment in developing its product ranges backed by experienced sales teams has placed it in a strong position to maintain its growth record.

Anpario plc
David Bullen, Chief Executive Officer +44 (0)791 955 2040
Karen Prior, Group Finance Director +44 (0)1909 537 380
FinnCap
Matthew Robinson / Henrik Persson - Corporate Finance
Stephen Norcross - Corporate Broking +44 (0)20 7600 1658

Copyright Business Wire 2014

Date   Source Headline
19th Jul 20072:29 pmRNSBlocklisting Interim Review
16th Jul 20072:00 pmRNSAdditional Listing
12th Jul 200711:30 amRNSTrading Statement
18th Jun 20079:24 amRNSRPM Production Stopped
4th Jun 20074:50 pmRNSDirector/PDMR Shareholding
4th Jun 200711:14 amRNSDirectorate Change
25th May 200710:18 amRNSMine Training Centre
4th May 200712:02 pmRNSDividend Declaration
26th Apr 20077:02 amRNSFinal Results
16th Apr 20073:02 pmRNSDirector/PDMR Shareholding
13th Apr 20073:11 pmRNSDirector/PDMR Shareholding
13th Apr 20073:06 pmRNSRustenburg Directorate
3rd Apr 20072:42 pmRNSDirector/PDMR Shareholding
2nd Apr 200711:17 amRNSDirectorate Change
30th Mar 20073:40 pmRNSAGM Statement
28th Mar 20072:51 pmRNSDirector/PDMR Shareholding
19th Mar 20071:10 pmRNSDividend re-investment
19th Mar 20071:01 pmRNSDirector/PDMR Shareholding
13th Mar 20072:10 pmRNSDividend conversion rate
13th Mar 200711:00 amRNSDirector/PDMR Shareholding
2nd Mar 200712:22 pmRNSDirectorate Change
2nd Mar 20079:34 amRNSRustenburg Platinum
2nd Mar 20079:13 amRNSDirector/PDMR Shareholding
27th Feb 20072:01 pmRNSDirectorate Change
14th Feb 20072:00 pmRNSDirectorate Change
12th Feb 20077:01 amRNSFinal Results
12th Feb 20077:00 amRNSDividend Declaration
18th Jan 20072:40 pmRNSBlocklisting Interim Review
15th Jan 20079:23 amRNSAdditional Listing
12th Jan 20073:30 pmRNSBlocklisting Interim Review
14th Dec 20061:05 pmRNSBEE Transaction
12th Dec 200610:00 amRNSAmandelbult mine
11th Dec 20069:15 amRNSPreference Shares
11th Dec 20069:00 amRNSConversion of pref shares
6th Dec 200611:45 amRNSDirectorate Change
6th Dec 200611:06 amRNSFacility visit
29th Nov 200612:00 pmRNSTrading Statement
27th Nov 200611:56 amRNSResult of EGM
9th Nov 200610:48 amRNSSchedule 1 - Kiotech Int. Plc
9th Nov 20067:00 amRNSFacility visit
8th Nov 20061:02 pmRNSDirector/PDMR Shareholding
8th Nov 200612:00 pmRNSBEE Transaction
7th Nov 20067:01 amRNSDirectorate Change
3rd Nov 20062:00 pmRNSAnooraq-Platinum Proj Update
3rd Nov 20067:30 amRNSRestoration- Kiotech Intl plc
3rd Nov 20067:30 amRNSAcquistion and Placing
27th Oct 20068:52 amRNSDividend Declaration
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.